Literature DB >> 11313411

Human cytomegalovirus pp65- and immediate early 1 antigen-specific HLA class I-restricted cytotoxic T cell responses induced by cross-presentation of viral antigens.

Z Tabi1, M Moutaftsi, L K Borysiewicz.   

Abstract

Dendritic cells (DCs) play a pivotal role in the development of anti-viral CD8(+) CTL responses. This is straightforward if they are directly infected with virus, but is less clear in response to viruses that cannot productively infect DCS: Human CMV (HCMV) shows strain-specific cell tropism: fibroblast (Fb)-adapted laboratory strains (AD169) and recent clinical isolates do not infect DCs, whereas endothelial cell-adapted strains (TB40/E) result in productive lytic DC infection. However, we show here that uninfected DCs induce CD8(+) T cell cytotoxicity and IFN-gamma production against HCMV pp65 and immediate early 1 Ags following in vitro coculture with HCMV-AD169-infected Fbs, regardless of the HLA type of these FBS: CD8(+) T cell stimulation was inhibited by pretreatment of DCs with cytochalasin B or brefeldin A, indicating a phagosome/endosome to cytosol pathway. HCMV-infected Fbs were not apoptotic as measured by annexin V binding, and induction of apoptosis of infected Fbs in vitro did not augment CTL induction by DCs, suggesting a mechanism other than apoptosis in the initiation of cross-presentation. Furthermore, HCMV-infected Fbs provided a maturation signal for immature DCs during coculture, as evidenced by increased CD83 and HLA class II expression. Cross-presentation of HCMV Ags by host DCs enables these professional APCs to bypass some of the evasion mechanisms HCMV has developed to avoid T cell recognition. It may also serve to explain the presence of immediate early 1 Ag-specific CTLs in the face of pp65-induced inhibition of Ag presentation at the level of the infected cell.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11313411     DOI: 10.4049/jimmunol.166.9.5695

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  22 in total

1.  Susceptibility of immature and mature Langerhans cell-type dendritic cells to infection and immunomodulation by human cytomegalovirus.

Authors:  Laura Hertel; Vashti G Lacaille; Herbert Strobl; Elizabeth D Mellins; Edward S Mocarski
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

2.  Cross-presentation of human cytomegalovirus pp65 (UL83) to CD8+ T cells is regulated by virus-induced, soluble-mediator-dependent maturation of dendritic cells.

Authors:  Géraldine Arrode; Claire Boccaccio; Jean-Pierre Abastado; Christian Davrinche
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

3.  Induction of anti-human immunodeficiency virus type 1 (HIV-1) CD8(+) and CD4(+) T-cell reactivity by dendritic cells loaded with HIV-1 X4-infected apoptotic cells.

Authors:  Xiao-Qing Zhao; Xiao-Li Huang; Phalguni Gupta; Luann Borowski; Zheng Fan; Simon C Watkins; Elaine K Thomas; Charles R Rinaldo
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

4.  Human cytomegalovirus elicits fetal gammadelta T cell responses in utero.

Authors:  David Vermijlen; Margreet Brouwer; Catherine Donner; Corinne Liesnard; Marie Tackoen; Michel Van Rysselberge; Nicolas Twité; Michel Goldman; Arnaud Marchant; Fabienne Willems
Journal:  J Exp Med       Date:  2010-04-05       Impact factor: 14.307

5.  An efficient strategy to induce and maintain in vitro human T cells specific for autologous non-small cell lung carcinoma.

Authors:  Glenda Canderan; Paola Gruarin; Daniela Montagna; Raffaella Fontana; Gabriele Campi; Giulio Melloni; Catia Traversari; Paolo Dellabona; Giulia Casorati
Journal:  PLoS One       Date:  2010-08-09       Impact factor: 3.240

6.  Impaired lymphoid chemokine-mediated migration due to a block on the chemokine receptor switch in human cytomegalovirus-infected dendritic cells.

Authors:  Magdalena Moutaftsi; Paul Brennan; Stephen A Spector; Zsuzsanna Tabi
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

7.  Enhanced antitumor effect of combining chemotherapy with Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes in mice with EBV-related non-Hodgkin's lymphoma.

Authors:  Rui Deng; Hai Yi; Yi-Lan Liu; Fang-Yi Fan; L I Fu; Ye-Cheng Li; Guo-Shun Li; Si-Han Lai; Xiao-Juan Miao; Yan-Rong Shuai; Guang-Cui He; Y I Wang; Yan Zeng; Hao-Ping Sun; Ling Qiu; Y I Su
Journal:  Mol Clin Oncol       Date:  2015-09-16

8.  A cytomegalovirus inhibitor of gamma interferon signaling controls immunoproteasome induction.

Authors:  Selina Khan; Albert Zimmermann; Michael Basler; Marcus Groettrup; Hartmut Hengel
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

Review 9.  Dynamics of T cell memory in human cytomegalovirus infection.

Authors:  Edward C P Waller; Elizabeth Day; J G Patrick Sissons; Mark R Wills
Journal:  Med Microbiol Immunol       Date:  2008-02-27       Impact factor: 3.402

Review 10.  VCL-CB01, an injectable bivalent plasmid DNA vaccine for potential protection against CMV disease and infection.

Authors:  Mark R Schleiss
Journal:  Curr Opin Mol Ther       Date:  2009-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.